Professor R. Keith Campbell, MBA, BPharm, CDE, now retired from Washington State University College of Pharmacy, highlights the clinical advantages of Afrezza based on the evidence as well as his personal perspective.
R. Keith Campbell, MBA, BPharm, CDE
Advertisement
Articles by R. Keith Campbell, MBA, BPharm, CDE
Advertisement
Latest Updated Articles
- Afrezza: Treating Diabetes in a Physiologic Manner
September 16th 2016
Advertisement
Advertisement
Trending on AJMC
1
FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week
2
Clesrovimab Demonstrates Safety Through a Second RSV Season in High-Risk Infants
3
Dermatology Practices Absorb Rising Prior Authorization Costs
4
Dry Eye Disease Is More Than "Dry Eyes": Experts Explain the 2 Types
5